| Literature DB >> 25579652 |
F Cagide1, T Silva, J Reis, A Gaspar, F Borges, L R Gomes, J N Low.
Abstract
The discovery of potent and selective monoamine oxidase-B inhibitors for the management of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases is still a challenging endeavor. Herein, we report the discovery of two new classes of potent and selective MAO-B inhibitors based on chromane-2,4-dione and chromone-3-carboxamide scaffolds.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25579652 DOI: 10.1039/c4cc08798d
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222